Audio Interview: Addressing the Omicron Variant of SARS-CoV-2

N Engl J Med. 2022 Jan 27;386(4):e16. doi: 10.1056/NEJMe2201214.
No abstract available

Publication types

  • Editorial
  • Interview
  • Webcast

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antiviral Agents / supply & distribution
  • Antiviral Agents / therapeutic use*
  • COVID-19 Drug Treatment*
  • COVID-19 Vaccines / administration & dosage*
  • COVID-19 Vaccines / immunology
  • COVID-19* / prevention & control
  • Drug Resistance, Viral / genetics
  • Health Services Accessibility*
  • Humans
  • Immunization, Secondary
  • Immunogenicity, Vaccine*
  • Patient Compliance
  • Public Health Practice
  • SARS-CoV-2* / drug effects
  • Vaccine Efficacy
  • Vaccines, Synthetic
  • mRNA Vaccines

Substances

  • Antibodies, Monoclonal
  • Antiviral Agents
  • COVID-19 Vaccines
  • Vaccines, Synthetic
  • mRNA Vaccine
  • mRNA Vaccines

Supplementary concepts

  • COVID-19 vaccine booster shot
  • SARS-CoV-2 variants